CLEARMIND MEDICINE INC (CMND) Stock Price, Quote, News and Overview
NASDAQ:CMND - Nasdaq - CA1850534027 - Common Stock - Currency: USD
CMND Quote, Performance and Key Statistics
CLEARMIND MEDICINE INC
NASDAQ:CMND (2/5/2025, 8:00:00 PM)
After market: 1.48 -0.01 (-0.67%)1.49
+0.12 (+8.76%)
The current stock price of CMND is 1.49 USD. In the past month the price decreased by -5.7%. In the past year, price increased by 2.76%.
CMND Latest News, Press Releases and Analysis
Clearmind Medicine Announces Publication of Patent for Binge Behavior Psychedelic Combination Treatment in Mexico
Clearmind Medicine Announces Publication of Patent for Binge Behavior Psychedelic Combination Treatment in Mexico
Vancouver, Canada, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the
Clearmind Medicine Announces Shareholders Meeting Results
Clearmind Medicine Announces Shareholders Meeting Results
Vancouver, Canada, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the “Company”), a...
Why Is Psychedelic-SciSparc Stock Trading Higher On Monday?
On Monday, SciSparc Ltd (NASDAQ:SPRC) stock is trading higher with a session volume of 30.86 million compared to an average volume of 7.73 million as per data from Benzinga Pro. SciSparc announced, as part of its ongoing collaboration with Clearmind Medicine Inc. (NASDAQ:CMND), the publication of a European patent application submitted by Clearmind under the European Patent Office for combination therapy of MEAI and N-Acylethanolamines for binge behavior, including alcohol consumption, eating, t
CMND Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 82.81 | 799.50B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 29.06 | 380.66B | ||
| JNJ | JOHNSON & JOHNSON | 15.48 | 372.43B | ||
| MRK | MERCK & CO. INC. | 11.74 | 226.83B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 18.62 | 219.98B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 13.86 | 219.54B | ||
| PFE | PFIZER INC | 8.5 | 149.84B | ||
| SNY | SANOFI-ADR | 13.51 | 134.13B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 51.03 | 121.10B | ||
| ZTS | ZOETIS INC | 30.5 | 79.26B | ||
| GSK | GSK PLC-SPON ADR | 9.11 | 76.92B | ||
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 31.09 | 42.39B |
Related stock screener links
About CMND
Company Profile
Clearmind Medicine, Inc. is a psychedelic pharmaceutical biotech company. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2021-08-10. The firm is focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorders. The firm researches and develops psychedelic-based compounds and attempts to commercialize them as regulated medicines, foods, or supplements. The Company’s intellectual portfolio consists of 15 patent families, including 27 granted patents and 24 pending applications. The portfolio spans a range of jurisdictions, including the United States, Europe, India, and China.
Company Info
CLEARMIND MEDICINE INC
101-1220 West 6Th Avenue
Vancouver BRITISH COLUMBIA CA
Employees: 0
Company Website: https://www.clearmindmedicine.com/
Investor Relations: http://www.clearmindmedicine.com/investors
Phone: 16042601566
CMND FAQ
What is the stock price of CMND?
The current stock price of CMND is 1.49 USD.
What is the symbol for CLEARMIND MEDICINE INC stock?
The exchange symbol of CLEARMIND MEDICINE INC is CMND and it is listed on the Nasdaq exchange.
On which exchange is CMND stock listed?
CMND stock is listed on the Nasdaq exchange.
Is CMND a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for CMND, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of CMND.
Does CMND stock pay dividends?
CMND does not pay a dividend.
What is the Price/Earnings (PE) ratio of CMND?
CMND does not have a PE ratio as the earnings reported over the last twelve months were negative (-12.73).
What is the Short Interest ratio of CMND stock?
The outstanding short interest for CMND is 10.08% of its float.
CMND Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to CMND. When comparing the yearly performance of all stocks, CMND is a bad performer in the overall market: 60.97% of all stocks are doing better.
CMND Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to CMND. CMND may be in some trouble as it scores bad on both profitability and health.
CMND Financial Highlights
Over the last trailing twelve months CMND reported a non-GAAP Earnings per Share(EPS) of -12.73. The EPS decreased by 65.74% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -103.26% | ||
| ROE | -243.02% | ||
| Debt/Equity | 0.01 |